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Background
The human microbiome, meaning the total group of
microbes that constantly populates a human being, has
been intensively studied in the lasts years. The gut
microbiota seems to be the most important part of it,
not just regarding the number of cells and diversity, but
for the almost unbelievable role in maintaining health,
acting on the immunity-disease axis. The gut can be
interpreted as a “microbial organ” and one obvious
aspect of its deterioration, mainly as result of antibiotics
misuse, is Clostridium difficile colitis.
In order to reverse the altered gut flora, a team consist-
ing of clinicians and microbiologists developed a protocol,
in accordance with internationals protocols, with specific
procedures, for performing fecal bacteriotherapy in
patients with recurrences of Clostridium difficile infection.
Fecal bacteriotherapy consists in transplantation of a small
quantity of feces from a healthy donor to another person
with abnormal intestinal flora.
Case report
Two female patients aged 80 respectively 83 years old
received fecal bacteriotherapy in our Institute, for the
second, respectively for the third Clostridium difficile
recurrence (ATLAS score <5); one case received the fecal
transplant by enema and one by nasogastric route. The
procedure was well tolerated. The evolution was favor-
able with rapid remission of diarrhea in the next 48 hours
and with no relapses in the 30 days of follow-up.
Conclusion
It is necessary to extend the experience with this treat-
ment, the fecal bacteriotherapy being a viable alternative
for Clostridium difficile infections failure to standard
treatment.
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